Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163/USP44 axis

MLA

Xin Ye, et al. “Increased M6A Modification of LncRNA DBH-AS1 Suppresses Pancreatic Cancer Growth and Gemcitabine Resistance via the MiR-3163/USP44 Axis.” Annals of Translational Medicine, vol. 10, Mar. 2022, p. 304. EBSCOhost, https://doi.org/10.21037/atm-22-556.

APA

Xin Ye, Li-Ping Wang, Cong Han, Hao Hu, Chen-Ming Ni, Guang-Lei Qiao, Liu Ouyang, & Jun-Sheng Ni. (2022). Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163/USP44 axis. Annals of Translational Medicine, 10, 304. https://doi.org/10.21037/atm-22-556

Chicago

Xin Ye, Li-Ping Wang, Cong Han, Hao Hu, Chen-Ming Ni, Guang-Lei Qiao, Liu Ouyang, and Jun-Sheng Ni. 2022. “Increased M6A Modification of LncRNA DBH-AS1 Suppresses Pancreatic Cancer Growth and Gemcitabine Resistance via the MiR-3163/USP44 Axis.” Annals of Translational Medicine 10 (March): 304. doi:10.21037/atm-22-556.